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ABSTRACT
The phage 029 protein p4, that controls viral late trans-
cription, was highly purified from Escherichia coli cells
harbouring a gene 4-containing plasmid. This protein, represen-
ting about 6% of the total cellular protein, was obtained in a
highly purified form. The protein was characterized as p4 by
amino acid analysis and NH -terminal sequence determination. The
purified protein was activi in an in vitro transcription assay,
allowing specific initiation of transcription a 3the +29 A3 late
promoter in the presence of Bacillus subtilis a -RNA polymerase
holoenzyme.
INTRODUCTI0I
Bacillus subtilis phage 029 contains a linear, double-
stranded DNA of 19,285 bp (1) with the viral protein p3
covalently linked at the two 5' ends (2). Phage p29 late genes
are clustered in the middle of the genome, flanked by the early
genes, localized at both ends on the viral genetic map (3). In
vivo early transcription takes place from the light DNA strand
from right to left, whereas the late transcription occurs from
the heavy DNA strand in the opposite direction (4,5). Synthesis
of early RNA is carried out by the host a43-RNA polymerase
holoenzyme, the product of the viral gene 4 being required to
transcribe the i29 late genes (6). The initiation sites of the
RNA transcripts synthesized in vivo in Bacillus subtilis
infected with bacteriophage #29 have been mapped by S1
protection experiments (7) and the early and late promoter
sequences determined (8). The B. subtilis RNA polymerase
containing the a subunit basically recognizes the same i29
promoters in vitro as those used in vivo (9). The #29 early
promoters have sequences homologous to the consensus ones
recognized by the a43-RNA polymerase from B. subtilis at their
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-10 and -35 regions (8,9), whereas the main late promoter A3
only shares homology with the consensus sequence at its -10
region. Transcription from the late promoter can take place in
vitro after prolonged incubation with the B. subtilis or E. coli
RNA polymerase holoenzymes in the absence of protein p4 (9,10),
although this transcription is negligible if the salt is
increased in the in vitro assay (10,11).
The 929 gene 4 was cloned and its product, protein p4,
overexpressed in E. coli (12,13). In this paper we report the
purification of protein p4 in an active form from the E. coli
cells. An in vitro assay has been deviced in which there is
specific recognition of the #29 A3 late promoter by the B.
subtilis a43-RNA polymerase in the presence of purified protein
p4.
MATERIALS AND METHODS
a) Bacterial strains, plasmids, proteins and radioactive
compounds.
B. subtilis llONA trp spoA su was used as a source of B.
subtilis RNA polymerase and as a host for the bacteriophage p29.
E. coli strain M72 SmR laczam bio-uvrB Atrp EA2 (X Nam7Nam53
cI857hHl), here designated K12AHlAtrp, was obtained from E.
Remaut and used as a host for the propagation of plasmids pRMn25
(13), pRMcn385 (13), pRMw5l (12), pRMs463 (12) and pRMtl2l (14).
Restriction endonucleases were from New England Biolabs,
nuclease S1 from PL Biochemicals, calf intestinal alkaline phos-
phatase, bacteriophage T4 polynucleotide kinase and the large
fragment of the E. coli DNA polymerase I (Klenow enzyme) from
Boehringer Mannheim. [y-32PATP (-3000 Ci/mmol), [-32PJdATP
(-400 Ci/mmol), [a-32P]UTP (-400 Ci/ mmol) and [35S]-methionine
(1200 Ci/mmol) were from Amersham International plc.
b) Preparation and labelling of nucleic acids. S1 mapping and
DNA sequence analysis.
029 DNA was prepared as described before (6). Total RNA was
isolated from i29 infected cells either in the presence or
absence of chloramphenicol as described (7). Labelling of DNA
fragments at their 5' termini with polynucleotide kinase and
y-32PJATP and at their 3' ends with [b-32PJdATP and the Klenow
enzyme was as described (15). Double and single-stranded DNAs
were purified by diffusion from polyacrylamide gels. Conditions
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for the protection of 5' end-labelled DNA or RNA to the Si
digestion were as described (7). DNA sequencing reactions were
as described (16).
c) Protein analysis and purification. In vitro transcription
assay.
E. coli cells harbouring the p4-overproducer plasmid pRMn25
or the plasmid pRMs463, containing a nonsense mutation in the
gene 4 cloned sequences, were grown at 300C, induced at 420C for
2 h and labelled for 10 min with [35 ]-methionine (80 pCi/ml) as
described (12). Fifteen g of E. coli K12AHlAtrp cells transfor-
med with the plasmid pRMn25 and induced for 2 h at 420C were
mixed with 35S-labelled cells, ground with alumina (30 g) and
extracted with buffer A (50 mM Tris-HCl, pH 7.0, 5% glycerol)
containing 1 M NaCl. The lysate was centrifuged for 10 min at
20,000 x g and the pellet reextracted with the same buffer. The
two supernatants were pooled, diluted with buffer A to bring the
NaCl concentration down to 0.5 M and passed through a phospho-
cellulose column (13 cm x 3.6 cm) equilibrated with buffer A
containing 0.5 M NaCl. The column was extensivelly washed with
the same buffer and protein p4 was recovered by addition of
buffer A containing 1 M NaCl. The p4-containing fractions were
pooled and made 0.5 M NaCl with buffer A before loading them in
a second phosphocellulose column (5 cm x 1.4 cm) equilibrated
with buffer A containing 0.5 M NaCl. After extensive washing,
protein p4 was eluted with the same buffer containing 0.6 M
NaCl. The equivalent fractions from a parallel purification of
cells containing the plasmid pRMs463, carrying the nonsense
mutation in gene 4, were used to prepare rabbit antibodies. The
purified IgGs (17) were then covalently bound to CNBr-activated
Sepharose 4B (Pharmacia), according to the supplier, to prepare
an affinity column equilibrated with PBS buffer (8.1 mM Na2HPO4,
1.47 mM KH2PO4, pH 7.4, 0.13 M NaCl, 2.68 mM KCl)) containing
0.01% Nonidet-P40. The pooled p4-containing fractions (half of
the sample) were passed through the affinity column (5.5 cm x
1.5 cm), protein p4 being recovered in the flow-through
fractions. The protein was finally concentrated in a phospho-
cellulose column (0.7 cm x 0.8 cm), and protein p4 was eluted
with buffer A containing 1 M NaCl.
B. subtilis a43-RNA polymerase was purified as described
(6). Protein concentration was determined by the method of
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Figure 1. Overproduction of the M29 protein p4 in E. coli. The
proteins contained in E. coli cells carrying the indicated
recombinant plasmids were analyzed in 10-20% polyacrylamide gels
in the presence of SDS after 2 h of induction at 420C, as
indicated in Materials and Methods, section c. a) Plasmid
pRMs463; b) plasmid pRMtl21; c) plasmid pRMwSl; d) plasmid
pRMn25. The position of protein p4 is indicated.
Bradford (18). Electrophoresis of proteins was carried out in
slab gels containing 10-20% acrylamide gradients in the presence
of 0.1% SDS (19). After electrophoresis, the proteins were
stained as described by Fairbanks et al. (20).
The in vitro transcription assay was as described by Sogo
et al. (6) modified as indicated in Mellado et al. (9).
d) Amino acid analysis and protein sequence determination.
Purified protein p4 was hydrolyzed with 100 pl of 5.7 M HCl
containing 0.05% (v/v) 2-mercaptoethanol in evacuated and sealed
tubes at 110° for 24, 48 and 72 h. The analysis were performed
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Figure 2. SDS-polyacrylamide gel electrophoresis of purified
protein p4. Proteins at various purification steps were
subjected to SDS-electrophoresis in slab gels containing a
10-20% polyacrylamide gradient. After electrophoresis the
proteins were stained as indicated in Materials and Methods,
section c. Lanes: a,b) extract (25.5 and 38.7 pg); c,d) first
phosphocellulose column, 1 M NaCl eluate (23.6 and 12.5 pg);
e,f) second phosphocellulose column, 0.6 M NaCl eluate (2.7 and
1.4 1ug); g,h) affinity column (0.9 and 0.03 mg). + and -
symbolize the use of cells harbouring plasmid pRMn25 and
pRMs463, respectively. The position of protein p4 is indicated.
on a Beckman 121-MB Analyzer equipped with a Shimadzu Integrator
model CR-3A.
Protein P4 was sequenced in a Beckman sequencer (model 890
M) according to the method of Edman and Begg (21). The sequence
of the protein was determined using the Beckman protein/peptide/
micro/macrosequencing program. To reduce peptide washout, 1 mg
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Table 1. Summary of the purification of protein p4
Total protein, Protein p4, Total protein p4,
mg % mg
Extract 1360 3.3 45.5
Phosphocellulose 1 180 8.8 15.8
Phosphocellulose 2 8.1 69 5.6
Affinity chromat. 2.5 >95 2.5
Total protein was determined by the method of Bradford
(18). SDS-polyacrylamide gel electrophoresis was carried out at
the different purification steps to follow the presence of
protein p4. For the affinity chromatography step, half of the
sample was used. The values summarized in this step are those
expected if the entire fraction had been subjected to the
affinity chromatography.
of polybrene was added when the sample was applied on the cup
(22). The PTH-amino acids were identified on a reverse-phase
HPLC system based upon a Nova-Pak C-18 column (Waters) and elu-
ted with the following buffer: A, 35 mM sodium acetate, pH 5.0:
acetonitrile (5:1); B, 2-propanol: water (3:2). The following
Waters program was used: 1 min at 0% B; 3.5 min, from 0% B to
40% B with a hyperbolic step (curve 4 in a Waters M-680 contro-
ller) followed by isocratic step of 3 min at 40% B. The column
was mantained at 380C and a flow rate of 1 ml/min was used.
RESULTS AND DISCUSSION
1. Synthesis and purification of protein p4.
E. coli K12AHlAtrp cells, carrying different p4-
overproducer plasmids, were grown and induced for 2 h as
indicated in Materials and Methods, section c, and the
synthesized polypeptides analyzed on SDS-polyacrylamide gels.
Figure 1 shows that plasmid pRMn25 (lane d) is the higher
producer, being the amount of protein p4 (Mr 15,000) synthesized
approximately 6% of the total cellular protein. Therefore, E.
coli cells carrying plasmid pRMn25 were used as a source of the
i29 protein p4. The cells were grown and lysed as indicated in
Materials and Methods, section c, and the extracted proteins
passed sequentially through two phosphocellulose columns, being
protein p4 finally purified by an affinity column made with
rabbit IgGs against the peptides present in a parallel
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Table 2. Amino acid composition of purified protein p4
Residue Predicteda Observedb
Asp+Asn 13 12.2
Thr 4 5.1
Ser 7 7.2
Glu+Gln 12 12.9
Pro 4 3.5
Gly 4 8.4
Ala 6 7.1
Val 8 7.7
Met 4 2.5
Ile 5 5.0
Leu 9 8.9
Tyr 7 6.3
Phe 7 6.6
Trp 4 N.D.
Lys 12 11.0
His 3 3.0
Arg 11 10.0
aAmino acid composition predicted from the
nucleotide sequence (23,24). The amino-terminal
Met, which is removed by processing, has not been
included.
bAmino acid composition of purified protein p4.
Each value represents the average after 24, 48 and
72 h hydrolysis except the values for Thr and Ser
that were extrapolated to zero hours of hydroly-
sis. Values represent residues per molecule. Trp
was not determined (N.D.).
purification of cells carrying plasmid pRMs463 that contains a
nonsense mutation in the cloned gene 4. Figure 2 shows the
analysis by SDS-polyacrylamide gel electrophoresis of the
different fractions of the purification. Densitometric analysis
of the protein at the final step indicated that p4 was more than
95% pure. Table 1 gives a summary of the purification. About 1.3
mg of protein p4 were obtained from 15 g of E. coli cells
harbouring the recombinant plasmid pRMn25.
2. Amino acid analysis of purified protein p4.
Table 2 shows that the amino acid analysis of the purified
protein p4 gives values very similar to those deduced from the
DNA sequence (23,24). Moreover, the NH2-terminal sequence of
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Figure 3. Activity of protein p4 at different salt concen-
trations. The i029 RA HindIII H fragment (-80 ng) was incubated
with B. subtilis a -RNA polymerase (2.4 pg) in the presence of
1 pg of protein p4 purified through the second phosphocellulose
column (+) or the equivalent volume from the parallel
purification of cell extracts containing the plasmid pRMs463
(-). The in vitro run-off assay was performed as indicated in
Materials and Methods, section c. The transcripts were analyzed
on a denaturing 4% polyacrylamide gel containing 7 M urea. The
transcripts sizes in nucleotides are indicated at the left
margin. The 470 nt and the 78 nt ones correspond to trans-
cription initiated at the A2c and A3 promoters, respectively.
The different ammonium sulfate concentrations present in the
incubation mixture were 72 mM (a,b), 90 mM (c,d) and 108 mM
(e,f).
purified protein p4 showed the sequence Pro-Lys-Thr-Gln-Arg-
Gly-Ile-Tyr-His, in agreement with the one predicted from the
nucleotide sequence if the first Met residue is processed in E.
coli.
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Figure 4. Specific transcription initiation at the A3 promoter
in the presence of protein p4. Transcripts made in the in vitro
rn-off assay (see legend to Figure 3) by the B. subtilis
a -RNA polymerase (a) in the presence of 1 pg of protein p4
purified through the second phosphocellulose step (+) or (b) in
the presence of the equivalent volume from the parallel
purification of cell extracts containing the plasmid pRMs463 (-)
were hybridized to the 5' end-labelled late strand from the 929
DNA HindIII H fragment and digested with the Sl nuclease as
indicated in Materials and Methods, section b. Twenty five pg of
RNA made in cells infected with i29 wild type in the absence of
chloramphenicol (-CM) were equally processed (c). The protected
oligodeoxinucleotides were analyzed on a denaturing 8%
polyacrylamide gel containing 7 M urea. Sequencing reactions
(G,A,T,C) were from the plasmid pAZa3O5 of known sequence (A.
zaballos, unpublished results). The size of the protected oligo-
nucleotide is indicated in the left margin.
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Figure 5. Template requirements for the in vitro transcription
mediated by protein p4. The 929 DNA HindIII H fragment was
shortened with the indicated endonucleases and the different
fragments were used as templates in the in vitro run-off assay.
The incubation mixtures were as in the legend of Figure 3, but
containing 84 mM (a-f) or 36 mM (g,h) ammonium sulfate. +, indi-
cates the presence of protein p4 purified through the affinity
column (0.25 pg); -, indicates the presence of the equivalent
volume from the parallel purification of cell extracts contai-
ning the plasmid pRMs463. Templates: (a,b) HinfI-HindIII frag-
ment, 1308 bp long (28 ng); (c,d) AccI-HindIII fragment, 198 bp
long (40 ng); (e-h) TaqI-HindIII fragment, 129 bp long (12 ng).
The transcripts were analyzed on a denaturing 4% polyacrylamide
gel containing 7 M urea. Figures at the left margin are the
sizes of the 929 DNA HindIII L (269), M (156) and N (72) frag-
ments carried as markers (m). Sizes of the run-off transcripts
are indicated at the right margins. The arrow in the map indi-
cates the start point and direction of transcription from the A3
late promoter.
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3. Protein p4 stimulates in vitro transcription initiation at
the R29 A3 late promoter.
The 029 A3 late promoter is recognized in vitro by the B.
subtilis a43-RNA polymerase at low (10) but not at high salt
concentration (10,11). To assay the activity of the purified
protein p4 on directing the transcription from the A3 promoter,
the a43-RNA polymerase was incubated with the 763 bp long
HindIII H fragment from i29 DNA, at high salt, in the presence
or absence of protein p4 and i-32PJUTP. The HindIII H fragment
contains the early promoters A2b and A2c, where the B. subtilis
a43-RNA polymerase mainly initiates transcription in vivo and in
vitro, respectively, and the main viral late promoter A3 (8,9).
The radioactively labelled transcripts were analyzed by
electrophoresis in denaturing polyacrylamide gels. Figure 3
shows that, at 72 mM (NH4)2S04, transcription initiation at the
A3 promoter, indicated by a run-off transcript 78 nt long, took
place either in the presence of p4 (lane a) or when the
equivalent fraction from the parallel purification of cells
carrying the plasmid containing a nonsense mutation in gene 4
was used (lane b). When the salt concentration of the incubation
mixture was increased to 90-108 mM (NH4)2S04, transcription
initiation at the A3 promoter was dependent on the presence of
purified protein p4 (lanes c-f). In addition to the 78 nt long
transcript, a band around 90 nt long was also observed. In all
cases, a run-off transcript 470 nt long, corresponding to
initiation at the A2c early promoter was seen, being independent
on the salt or on protein p4.
When the corresponding Sl mapping experiment was done with
the RNA synthesized in vitro at 90 mM (NH4)2S04, hybridizing the
unlabelled RNA to the 5'end-labelled late strand of the HindIII
H fragment, only the 78 nt long transcript was protected from
the Sl digestion (Fig. 4a). The length of the transcript was
identical to that of the RNA made in vivo in cells infected with
929 in the absence of chloramphenicol (Fig. 4c). No transcript
was protected from the S1 digestion when the fraction from the
purification of cell extracts containing the plasmid carrying a
nonsense mutation in gene 4 was used in the in vitro assay (Fig.
4b). The 90 nt long transcript was not protected from the Sl
digestion, suggesting that it was due to an initiation and
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termination event within the HindIII H fragment. Truncated
template studies confirmed this possibility (not shown).
To determine the DNA sequence requirements for the in
vitro stimulation of transcription at the A3 promoter by protein
p4, different subfragments from the HindIII H DNA fragment have
been used as templates in the run-off transcription assay. As
shown in Fig. 5, in the presence of the B. subtilis a43-RNA
polymerase and purified protein p4 at 90 mM (NH4)2S04, both, the
308 bp long HinfI-HindIII and the 198 bp long AccI-HindIII
subfragments showed to be good templates for the p4-dependent A3
transcription (Fig. 5, lanes a-d), whereas the 129 bp long
TaqI-HindIII subfragment was not (Fig. 5, lanes e and f). When
low salt was used in the assay, the TaqI-HindIII subfragment
showed to be a good template for the p4-independent
transcription initiated at the A3 promoter (Fig. 5, lanes g and
h). Therefore, deletion of the DNA sequences comprised between
the AccI and TaqI sites in the HindIII H fragment resulted in
the lost of p4-dependance for the A3 transcription. The deleted
region includes an AT-rich sequence upstream the A3 promoter and
a correlation among the strength of promoters and the presence
of upstream AT-rich regions has been proposed (25). Protein p4
could be a DNA-binding protein since it contains the
helix-turn-helix motif (26) present in DNA binding proteins
(27). Alternatively, the size of the TaqI-HindIII fragment could
be not long enough for the p4-dependent transcription to
initiate at the A3 promoter. Experiments aiming to clarify this
point are in progress.
The specificity of protein p4 on the in vitro initiation
of transcription from the 029 A3 late promoter will be an useful
tool to gain further insight on the understanding of the 029
late transcriptional control.
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